NCT06832059Active, not recruiting
Precision Nutrition Versus Standard Dietary Care: Continuous Glucose Monitoring as a Tool for Guided Nutrition Care in Type 2 Diabetes - The PRECISE-DIET Trial. -A Pilot Study
Source: ClinicalTrials.gov · Last updated 1 Jul 2026
Brief summary (registry, in English)
The primary aim of this pilot study is to assess the feasibility of a 12-week dietary intervention combined with the use of CGM in adults with T2D. The results of the pilot study will provide insights into recruitment, design, and the effectiveness of the intervention for the future long-term (12-month) PRECISE-DIET STUDY
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 9 Jan 2025
- Start date
- 18 Nov 2025
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Diseases
- Type 2 diabetes
- NCT number
- NCT06832059
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 18 Nov 2025 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with insulin.
- Low daily carbohydrate intake (defined as below 25 E% or 100 g/day) prior to study inclusion.
- Systematic use of corticosteroids.
- Known or suspected drug or alcohol abuse (judged by the investigator).
Lab values
- Complications which do not permit to lowering HbA1c to \<58 mmol/mol.
- Circumstances that affect HbA1c (e.g., liver disease and anaemia).
Other
- Inability to understand the patient information.
- Using or requiring a specialized diet (e.g., kidney diet).
- Pregnancy or breastfeeding or plans of pregnancy within the study period.
- Participation in other clinical trials.
Who the study is looking for
- T2D
- Diabetes duration of ≥12 months
- ≥18 years of age
- HbA1c ≥58 mmol/mol
- Attending the SDCC outpatient clinic
- Provided voluntary signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Steno Diabetes Center Copenhagen Coordinator of this site? Confirm its status | Herlev | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.